Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-01 23:39:15 - browse：618

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Churchill Downs extends trainer Bob Baffert's ban through 2024

WSS

Snackable artificial intelligence, expert AI, and the pharma industry

Covid hospitalizations on the rise, Humana says

A rare thyroid diagnosis led to unexpected, all

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

10 states plan to sue EPA over standards for residential wood

A rare thyroid diagnosis led to unexpected, all

entertainment

Wikipedia

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A rare thyroid diagnosis led to unexpected, all

Apple is now the first public company to be valued at $3 trillion

Elon Musk announces 'temporary limits' for reading Twitter posts

Jerome Adams on the need for new antivirals for Covid

Humana sues Biden admin over Medicare Advantage audit rule

Hepatitis C has a cure — but many Americans still lack access to it

Snackable artificial intelligence, expert AI, and the pharma industry

United colonoscopy coverage change 'may cost lives,' doctors say

A new House health package & hospitals’ new site

hotspot

10 states plan to sue EPA over standards for residential wood

A timeline of the missing Titanic tourist submersible

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Ethical issues complicate the benefits of medical crowdfunding

US recommends Americans reconsider traveling to China due to arbitrary law enforcement, exit bans

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

explore

focus

focus

knowledge